Chas Mckhann serves as Executive at Apollo Endosurgery, Inc., where they oversee executive responsibilities. Since joining the company, Chas Mckhann has executed 15 insider transactions totaling $1.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 17, 2024 involved receiving (via award) 1,299,042 shares valued at $0.
Chas Mckhann currently holds 1,299,042 shares of Apollo Endosurgery, Inc. (APEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chas Mckhann has been a net seller of APEN stock. They have purchased $0 and sold $1.0M worth of shares.
Chas Mckhann's most recent insider trade was on Sep 17, 2024, when they sold 1,299,042 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 17, 2024 | SILK | $0 | Disposition | 722,396 | $N/A | Discretionary |
| Mar 1, 2024 | SILK | $0 | Award | 110,313 | $N/A | Discretionary |
| Nov 2, 2023 | SILK | $0 | Award | 612,083 | $N/A | Discretionary |
| Apr 4, 2023 | APEN | $0 | Disposition | 689,880 | $N/A | Discretionary |
| Jun 14, 2022 | APEN | $0 | Award | 112,607 | $N/A | Discretionary |
| May 5, 2022 | APEN | $360.7K | Payment | 66,553 | $5.42 | Discretionary |
| Aug 20, 2021 | APEN | $163.7K | Sale | 21,148 | $7.74 | Discretionary |
| Aug 20, 2021 | APEN | $163.7K | Sale | 21,148 | $7.74 | Discretionary |
| Aug 19, 2021 | APEN | $166.9K | Sale | 21,148 | $7.89 | Discretionary |
| Aug 19, 2021 | APEN | $166.9K | Sale | 21,148 | $7.89 | Discretionary |
| Aug 18, 2021 | APEN | $173.7K | Sale | 21,156 | $8.21 | Discretionary |
| Aug 18, 2021 | APEN | $173.7K | Sale | 21,156 | $8.21 | Discretionary |
| Mar 10, 2021 | APEN | $0 | Award | 707,278 | $N/A | Discretionary |